- Home
- UTHR vs RVTY Comparison
UTHR vs RVTY Comparison
Compare UTHR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- RVTY
- Stock Information
- Founded
- UTHR 1996
- RVTY 1937
- Country
- UTHR United States
- RVTY United States
- Employees
- UTHR N/A
- RVTY N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- UTHR Health Care
- RVTY Industrials
- Exchange
- UTHR Nasdaq
- RVTY Nasdaq
- Market Cap
- UTHR 15.5B
- RVTY 15.1B
- IPO Year
- UTHR 1999
- RVTY N/A
- Fundamental
- Price
- UTHR $372.89
- RVTY $112.01
- Analyst Decision
- UTHR Buy
- RVTY Buy
- Analyst Count
- UTHR 14
- RVTY 16
- Target Price
- UTHR $370.86
- RVTY $129.40
- AVG Volume (30 Days)
- UTHR 371.9K
- RVTY 1.1M
- Earning Date
- UTHR 10-30-2024
- RVTY 11-04-2024
- Dividend Yield
- UTHR N/A
- RVTY 0.25%
- EPS Growth
- UTHR 25.10
- RVTY N/A
- EPS
- UTHR 22.72
- RVTY 2.06
- Revenue
- UTHR $2,756,200,000.00
- RVTY $2,721,555,000.00
- Revenue This Year
- UTHR $26.32
- RVTY $2.34
- Revenue Next Year
- UTHR $10.37
- RVTY $5.58
- P/E Ratio
- UTHR $16.41
- RVTY $53.54
- Revenue Growth
- UTHR 25.04
- RVTY N/A
- 52 Week Low
- UTHR $208.62
- RVTY $86.30
- 52 Week High
- UTHR $417.82
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- UTHR 50.17
- RVTY 36.55
- Support Level
- UTHR $353.65
- RVTY $107.17
- Resistance Level
- UTHR $417.82
- RVTY $114.13
- Average True Range (ATR)
- UTHR 11.15
- RVTY 3.88
- MACD
- UTHR -3.43
- RVTY -0.95
- Stochastic Oscillator
- UTHR 29.98
- RVTY 21.67
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.